Corey Langer, MD, is a Professor of Medicine at the University of Pennsylvania, the Clinical Director of Thoracic Oncology at the Abramson Cancer Center and Chair of the Medical Oncology Committee for the Radiation Therapy Oncology Group (RTOG), now NRG Oncology.
Dr Langer received his medical degree from Boston University, MA and completed his internship and residency in medicine at the Graduate Hospital of the University of Pennsylvania in Philadelphia. He is board certified in internal medicine and in hematology/oncology.
He is a Fellow of the American College of Physicians (ACP) and a member of the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR), and the International Association for the Study of Lung Cancer (IASLC). He brings extensive clinical trial experience to research in the Cooperative Group system (Radiation Therapy Oncology Group [RTOG] and Eastern Cooperative Oncology Group [ECOG]), and is a core member of both the RTOG/NRG and ECOG Head and Neck Cancer and Thoracic Committees.
Over the past 28 years he has led or co-led over 120 clinical trials in both small cell and non-small cell lung cancer, in the adjuvant, locally advanced and advanced disease setting, and at least 20 trials in head and neck cancer. His clinical research efforts include new drug combinations and special populations and, more recently, his focus has been on immuno-oncology trials. He is now very active in mentoring junior investigators as they launch their own clinical trials, and leads clinical research in thoracic malignancy as part of the Abramson Cancer Center’s Interdisciplinary Thoracic Oncology Program (ITOP). He has authored or co-authored over 170 peer-reviewed papers, primarily focussed on the treatment of smoking-related malignancies.